Publications by authors named "Arthur Santora"

Claim this Profile
O
Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 study.
Liana Tripto-Shkolnik, Auryan Szalat, Gloria Tsvetov, Vanessa Rouach, Chana Sternberg, Arthur C Santora

J Bone Miner Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial.
Socrates Papapoulos, Henry Bone, Felicia Cosman, David W Dempster, Michael R McClung, Arthur Santora

J Bone Miner Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
History of alendronate.
Steven R Cummings, Arthur C Santora, Dennis M Black, R Graham G Russell

Bone· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its Extension.
Robert Recker, David Dempster, Bente Langdahl, Hilde Giezek, Seth Clark, Arthur Santora

J Bone Miner Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
Michael R McClung, Michelle L O'Donoghue, Socrates E Papapoulos, Henry Bone, Bente Langdahl, Arthur Santora

Lancet Diabetes Endocrinol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label study of treatment with alendronate sodium plus vitamin D in men and women with osteoporosis in Thailand.
Thawee Songpatanasilp, Sattaya Rojanasthien, Pansak Sugkraroek, Boonsong Ongphiphadhanakul, Lamar Robert, Arthur C Santora

BMC Musculoskelet Disord· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating Atypical Features of Femur Fractures: How Change in Radiological Criteria Influenced Incidence and Demography of Atypical Femur Fractures in a Community Setting.
Erin S LeBlanc, A Gabriela Rosales, Dennis M Black, Harry K Genant, Richard M Dell, Arthur C Santora

J Bone Miner Res· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis.
Johan Halse, Susan Greenspan, Felicia Cosman, Graham Ellis, Arthur Santora

J Clin Endocrinol Metab· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin d binding protein and vitamin d levels.
Zhongjian Xie, Arthur C Santora, Sue A Shapses, Xiangbing Wang

Int J Endocrinol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D status and bone mineral density changes during alendronate treatment in postmenopausal osteoporosis.
Christian Roux, Neil Binkley, Steven Boonen, Douglas P Kiel, Stuart H Ralston, Arthur Santora

Calcif Tissue Int· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate.
Brian Louis McNabb, Eric Vittinghoff, Ann V Schwartz, Richard Eastell, Douglas C Bauer, Arthur Santora

J Bone Miner Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo responses to high and low doses of nitrogen-containing bisphosphonates suggest engagement of different mechanisms for inhibition of osteoclastic bone resorption.
John E Fisher, Elizabeth Rosenberg, Arthur C Santora, Alfred A Reszka

Calcif Tissue Int· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and demography of femur fractures with and without atypical features.
Adrianne C Feldstein, Dennis Black, Nancy Perrin, A Gabriela Rosales, Darin Friess, Arthur Santora

J Bone Miner Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of alendronate and vitamin D₃ on fractional calcium absorption in a double-blind, randomized, placebo-controlled trial in postmenopausal osteoporotic women.
Sue A Shapses, David L Kendler, Richard Robson, Karen E Hansen, Robert M Sherrell, Arthur C Santora

J Bone Miner Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiency.
Stuart H Ralston, Neil Binkley, Steven Boonen, Douglas P Kiel, Jean-Yves Reginster, Arthur Santora

Calcif Tissue Int· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect.
John A Eisman, Henry G Bone, David J Hosking, Michael R McClung, Ian R Reid, Arthur C Santora

J Bone Miner Res· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density.
Henry G Bone, Michael R McClung, Christian Roux, Robert R Recker, John A Eisman, Arthur C Santora

J Bone Miner Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
Dennis M Black, Michael P Kelly, Harry K Genant, Lisa Palermo, Richard Eastell, Arthur Santora

N Engl J Med· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial.
Neil Binkley, Johann D Ringe, John I Reed, Osten Ljunggren, Michael F Holick, Arthur C Santora

Bone· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.
Dennis M Black, Ann V Schwartz, Kristine E Ensrud, Jane A Cauley, Silvina Levis, Arthur C Santora

JAMA· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial.
Robert Recker, Paul Lips, Dieter Felsenberg, Kurt Lippuner, Laurent Benhamou, Arthur C Santora

Curr Med Res Opin· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study.
Shinji Uchida, Tadaaki Taniguchi, Takafumi Shimizu, Taro Kakikawa, Kotoba Okuyama, Arthur C Santora

J Bone Miner Metab· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk?
Henry G Bone, Arthur C Santora, Arghya Chattopadhyay, Uri Liberman

J Bone Miner Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in bone density and turnover after alendronate or estrogen withdrawal.
Richard D Wasnich, Yu Z Bagger, David J Hosking, Michael R McClung, Mei Wu, Arthur C Santora

Menopause· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoporosis and fracture risk in women of different ethnic groups.
Elizabeth Barrett-Connor, Ethel S Siris, Lois E Wehren, Paul D Miller, Thomas A Abbott, Arthur C Santora

J Bone Miner Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis